As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...

Significant changes at Johnson & Johnson were among the most-read medtech news on MassDevice over the past year.

Abstract: In this paper, the sliding mode control (SMC) problem is investigated for continuous stirred tank reactor (CSTR) via dynamic self-triggered protocol subject to external disturbance. By ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

Mortality rates are high in patients with type 1 diabetes, and overweight and obesity appear to be major factors, a speaker ...

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD).

In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings. The recall affects approximately 3 million sensors and was caused by an ...